Cargando…
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391226/ https://www.ncbi.nlm.nih.gov/pubmed/35995310 http://dx.doi.org/10.1016/j.jinf.2022.08.015 |
| _version_ | 1784770827124736000 |
|---|---|
| author | Mizoue, Tetsuya Yamamoto, Shohei Konishi, Maki Oshiro, Yusuke Inamura, Natsumi Nemoto, Takashi Ozeki, Mitsuru Horii, Kumi Okudera, Kaori Sugiyama, Haruhito Aoyanagi, Nobuyoshi Sugiura, Wataru Ohmagari, Norio |
| author_facet | Mizoue, Tetsuya Yamamoto, Shohei Konishi, Maki Oshiro, Yusuke Inamura, Natsumi Nemoto, Takashi Ozeki, Mitsuru Horii, Kumi Okudera, Kaori Sugiyama, Haruhito Aoyanagi, Nobuyoshi Sugiura, Wataru Ohmagari, Norio |
| author_sort | Mizoue, Tetsuya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9391226 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The British Infection Association. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93912262022-08-22 Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants Mizoue, Tetsuya Yamamoto, Shohei Konishi, Maki Oshiro, Yusuke Inamura, Natsumi Nemoto, Takashi Ozeki, Mitsuru Horii, Kumi Okudera, Kaori Sugiyama, Haruhito Aoyanagi, Nobuyoshi Sugiura, Wataru Ohmagari, Norio J Infect Letter to the Editor The British Infection Association. Published by Elsevier Ltd. 2022-11 2022-08-20 /pmc/articles/PMC9391226/ /pubmed/35995310 http://dx.doi.org/10.1016/j.jinf.2022.08.015 Text en © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Mizoue, Tetsuya Yamamoto, Shohei Konishi, Maki Oshiro, Yusuke Inamura, Natsumi Nemoto, Takashi Ozeki, Mitsuru Horii, Kumi Okudera, Kaori Sugiyama, Haruhito Aoyanagi, Nobuyoshi Sugiura, Wataru Ohmagari, Norio Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title | Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title_full | Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title_fullStr | Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title_full_unstemmed | Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title_short | Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants |
| title_sort | sensitivity of anti-sars-cov-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the omicron variants |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391226/ https://www.ncbi.nlm.nih.gov/pubmed/35995310 http://dx.doi.org/10.1016/j.jinf.2022.08.015 |
| work_keys_str_mv | AT mizouetetsuya sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT yamamotoshohei sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT konishimaki sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT oshiroyusuke sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT inamuranatsumi sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT nemototakashi sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT ozekimitsuru sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT horiikumi sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT okuderakaori sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT sugiyamaharuhito sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT aoyanaginobuyoshi sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT sugiurawataru sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants AT ohmagarinorio sensitivityofantisarscov2nucleocapsidproteinantibodyforbreakthroughinfectionsduringtheepidemicoftheomicronvariants |